News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
Positive Bioscience will offer Biodesix's liquid biopsy tests for non-small cell lung cancer in India.
The funds come from an equity investment by Chinese health firm iCarbonX announced at the beginning of the year as part of a partnership between the companies.
The investment bank also assigned a price target of $194 per share to the life science tools and diagnostics firm's stock.
Called the Glyco Liver Profile, the test uses capillary electrophoresis to measure glycosylation of proteins to diagnosis and monitor chronic liver diseases.
The deal gives BD global distribution rights for several Bruker MALDI Biotyper products, expanding a 2010 agreement key to both firms' microbiology businesses.